At the recent 74th annual American Diabetes Association Scientific Session in San Francisco, results from a simultaneously published article in the New England Journal of Medicine were formally announced. The publication consisted of two separate studies demonstrating the efficacy and safety of an “artificial” or “bionic” pancreas for people with type 1 diabetes.